Literature DB >> 2348430

Ovarian function studies in active ankylosing spondylitis in women. Clinical response to estrogen therapy.

F J Jimenez-Balderas1, R Tapia-Serrano, J I Madero-Cervera, S Murrieta, G Mintz.   

Abstract

Ovarian function was studied in 17 women with active ankylosing spondylitis (AS). Levels of FSH, LH, prolactin and androstenedione were normal in menstruating patients and FSH and LH were elevated in menopausal patients. In menstruating patients with active AS the estradiol levels were lower than in patients with inactive AS and significantly (p less than 0.05) lower than controls. Progesterone levels in menstruating patients were lower (P = NS) than controls. In menopausal patients estrogen levels were lower than their controls (P = NS). There was a significant (p less than 0.05) inverse correlation between the sedimentation rate and the estrogen level. Seven patients accepted oral estrogen therapy (average duration 4 months) and peripheral arthritis subsided within one month, all variables of clinical activity of AS improved and at the end of the study all patients were in functional class I.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2348430

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  Autophagy-related IRGM genes confer susceptibility to ankylosing spondylitis in a Chinese female population: a case-control study.

Authors:  Q Xia; M Wang; X Yang; X Li; X Zhang; S Xu; Z Shuai; J Xu; D Fan; C Ding; F Pan
Journal:  Genes Immun       Date:  2016-12-29       Impact factor: 2.676

2.  Somatosensory evoked potential findings in ankylosing spondylitis.

Authors:  Muharrem Cidem; Zerrin Sahin; Teoman Aydin; Fikret Aysal
Journal:  Eurasian J Med       Date:  2014-02

Review 3.  Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis.

Authors:  Rachael Stovall; Irene E van der Horst-Bruinsma; Shao-Hsien Liu; Tamara Rusman; Lianne S Gensler
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

Review 4.  Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.

Authors:  T Rusman; R F van Vollenhoven; I E van der Horst-Bruinsma
Journal:  Curr Rheumatol Rep       Date:  2018-05-12       Impact factor: 4.592

5.  Can the Second to Fourth Digit Ratio (2D : 4D) Be a Marker to Determine Ankylosing Spondylitis Disease Activity?

Authors:  Sevcan Uğur; Hasan Fatih Çay; İlhan Sezer; Cahit Kaçar
Journal:  Dis Markers       Date:  2019-02-11       Impact factor: 3.434

6.  A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis.

Authors:  Irene van der Horst-Bruinsma; Corinne Miceli-Richard; Juergen Braun; Helena Marzo-Ortega; Karel Pavelka; Alan J Kivitz; Atul Deodhar; Weibin Bao; Brian Porter; Effie Pournara
Journal:  Rheumatol Ther       Date:  2021-10-07

Review 7.  The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders.

Authors:  Eugenia Bertoldo; Giovanni Adami; Maurizio Rossini; Alessandro Giollo; Giovanni Orsolini; Ombretta Viapiana; Davide Gatti; Angelo Fassio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555

8.  Estrogen attenuates the spondyloarthritis manifestations of the SKG arthritis model.

Authors:  Hyemin Jeong; Eun-Kyung Bae; Hunnyun Kim; Yeong Hee Eun; In Young Kim; Hyungjin Kim; Jaejoon Lee; Chan Hong Jeon; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Arthritis Res Ther       Date:  2017-09-07       Impact factor: 5.156

9.  Ankylosing spondylitis: etiology, pathogenesis, and treatments.

Authors:  Xu Cao; Xisheng Weng; Wei Zhu; Xuxia He; Kaiyuan Cheng; Linjie Zhang; Di Chen; Xiao Wang; Guixing Qiu
Journal:  Bone Res       Date:  2019-08-05       Impact factor: 13.567

10.  Selective estrogen receptor modulator lasofoxifene suppresses spondyloarthritis manifestation and affects characteristics of gut microbiota in zymosan-induced SKG mice.

Authors:  Hyemin Jeong; In Young Kim; Eun-Kyung Bae; Chan Hong Jeon; Kwang-Sung Ahn; Hoon-Suk Cha
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.